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To the Editor:
Clinical overlap often confounds accurate diagnosis. For
a number of pleiotropic genetic syndromes, sophisticated
biochemical, molecular, and cytogenetic tests have mit-
igated this problem. However, for a laboratory result to
be of value to the practitioner, there must be no doubt
about the accuracy of the diagnosis for those patients
on which the laboratory test was validated. In their fore-
going letter to the Editor, Shanske et al. express concern
about our clinical diagnosis of Marshall syndrome in a
family in which we found a mutation in a gene encoding
a subunit of type XI collagen. To address their concern,
we shall review the clinical findings in the family de-
scribed by Marshall (1958), for whom the syndrome is
named, and compare these findings to those reported for
our patients (Griffith et al. 1998) and for the patients
described by Shanske et al. (1997), who also were
thought to have Marshall syndrome.
Marshall (1958) reported “a kindred of seven indi-
viduals in three generations, who showed the following
ocular abnormalities: congenital and juvenile cata-
racts,)basic myopia; fluid vitreous; and one instance of
retinal detachment); these patients also had defective
hearing, a congenital defect of the nose and the asso-
ciated facies, and other evidence suggestive that theymay
represent incomplete examples of hereditary anhidrotic
ectodermal dysplasia” (p. 143). In addition to anhidrotic
ectodermal dysplasia, Marshall included in his differ-
ential diagnosis “congenital syphilis, gargoylism, achon-
droplasia, and (distinct facies) even alone in an otherwise
normal body” (pp. 144–145). Not included in his dif-
ferential diagnosis were Stickler syndrome (Stickler et al.
1965) and Weissenbacher-Zweymu¨ller syndrome (Weis-
senbacher and Zweymu¨ller 1964), which had not yet
been described. After careful clinical assessment and ex-
amination of the dermal histology of two family mem-
bers, Marshall stated, “This kindred lacks the triad
found basically in the major, anhidrotic type of ecto-
dermal dysplasia: hypotrichosis, hypodontia, and hy-
pohidrosis. There is some evidence of the presence of
the latter two conditions, but this is not strongly con-
vincing” (p. 155). Did these patients really have a form
of ectodermal dysplasia, or did Marshall expand the
differential diagnosis of congenital nasal defect by de-
scribing a new nonectodermal dysplasia syndrome that
now bears his name? We and others (Cohen et al. 1974;
Zellweger et al. 1974; Lyons-Jones 1997, pp. 252–253)
think that the latter conclusion is more likely. Shanske
et al. (1997) disagree and refer to a four-generation kin-
dred with ectodermal abnormalities and hypertelorism,
which they feel is consistent with Marshall syndrome.
As detailed below, a comparison of the principal find-
ings reported by Marshall (1958) with the findings re-
ported for our patients (Griffith et al. 1998) reveals high
concordance, whereas comparison with the patients re-
ported by Shanske et al. (1997) shows low concordance.
Marshall’s patients and our patients all had congenital
or juvenile cataracts and fluid vitreous; none of the pa-
tients described by Shanske et al. had these conditions.
Marshall’s patients and our patients all had significant
hearing loss; none of the patients described by Shanske
et al. had hearing loss. Marshall’s patients had “ample
and normal hair,” as did our patients; the patients de-
scribed by Shanske et al. all had “sparse” hair or a “pau-
city of hair.” Two of Marshall’s patients were studied
radiographically; each had nasal bones that were “small,
short, and far back of their normal position.” These
patients also had “prominence of the frontal bossae,”
which served to “accentuate the flatness or depression
of the bridge of the nose,” and “thickening of the outer
table of the skull and absent frontal sinuses.” In our
report (Griffith et al. 1998), we included a patient pho-
tograph and cranial CT scan that showed nearly iden-
tical features. In contrast, the patients described by Shan-
ske et al. had “significant frontal recession” and normal
skeletal surveys.
Why did Shanske et al. conclude that their patients
had Marshall syndrome? One reason seems to be the
presence of ectodermal abnormalities, including sparse
hair, eyebrows, and eyelashes, in their patients.However,
Marshall’s patients did not have these ectodermal ab-
normalities. Instead, Marshall thought that his patients
had an altered ability to sweat. When comparing his
patients with a 32-year-old female control, Marshall ob-
served that sweat production was “diminished, perhaps
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25 percent below normal” (p. 148). However, the pa-
tients described by Shanske et al. did not have problems
with sweating. A second reason that Shanske et al. fa-
vored a diagnosis of Marshall syndrome was the pres-
ence of myopia in their patients; however, in addition
to basic myopia, Marshall’s patients had cataracts and
fluid vitreous, which the patients described by Shanske
et al. lacked. A third reason that Shanske et al. consid-
ered Marshall syndrome was the presence of ocular hy-
pertelorism in all of their patients. After inspecting the
published facial photographs of six of Marshall’s pa-
tients, Shanske et al. noted that one of the six (patient
6) had “striking ocular hypertelorism.”We tend to agree
with this assessment and suspect thatMarshall’s patients
2, 4, and 7 also might have had mild ocular hyperte-
lorism. However, “mild orbital hypertelorism” was in-
cluded in the figure legend accompanying the published
photograph of one of our patients (Griffith et al. 1998,
p. 819).
We feel strongly that this detailed comparison sup-
ports the clinical diagnosis of Marshall syndrome in our
kindred. A separate issue is whether the clinically defined
Marshall, Stickler, Weissenbacher-Zweymu¨ller, and
Wagner syndromes represent locus heterogeneity, allelic
heterogeneity, or variable expression of the same mu-
tation. In our report (Griffith et al. 1998), we discussed
the similarity and possible identity of Marshall syn-
drome and Stickler syndrome. Yet, there are precedents
for consideration of the possibility that clinically distinct
phenotypes also can result from allelic heterogeneity; for
example, FGFR3 mutations cause both achondroplasia
and thanatophoric dysplasia. On the basis of published
studies, we suggest the following conclusions: First,
Stickler syndrome exhibits locus heterogeneity with
mutations identified and shown to cosegregate in at
least three different genes, COL2A1, COL11A1, and
COL11A2; thus far, COL11A2 mutations have been
identified only in families lacking eye involvement but
otherwise having other component features of Stickler
syndrome. Second, the autosomal recessive disorder
oto-spondylo-megaepiphyseal dysplasia (Giedion et al.
[1982] concluded that the patient described by Weissen-
bacher and Zweymu¨ller [1964] had this disorder) also
appears to be due to mutation within the COL11A2
gene. Third, Wagner syndrome is genetically distinct
from both Stickler andMarshall syndromes, having been
mapped by linkage analysis to a novel locus on human
chromosome 5, by use of DNA from the kindred orig-
inally reported by Wagner (Brown et al. 1995). This
kindred had ocular involvement without the systemic
findings reported to occur with Marshall and Stickler
syndromes (Graemiger et al. 1995). Last, in at least one
kindred, Marshall syndrome is caused by a mutation
within COL11A1 (Griffith et al. 1998).
We fully agree with Shanske et al. (1997) that accurate
syndrome diagnosis is necessary in order to draw mean-
ingful conclusions about the molecular pathogenesis of
a disease phenotype. Results from one family are not
sufficient to determine whether COL11A1 will be the
sole Marshall syndrome locus or whether identical mu-
tations in COL11A1 (or in other loci) can cause Mar-
shall syndrome in one instance and Stickler syndrome
in another. If the unexpected, yet exciting, findings from
studies of other collagens are any indication (e.g.,
O’Reilly et al. 1997), studies of collagen XI will continue
to yield intriguing results. For now, we speculate that
mutations in COL11A1 cause Marshall syndrome, and
we invite our clinical and scientific colleagues to assist
us in testing this hypothesis.
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